8 Results for "

KG1

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "KG1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P9939
CAS No.: 1610833-03-8
Synonyms: KRN23; N5KG1_C10_LH; UX-023

Target:  

Inhibitory Antibodies

Research Areas:  

Metabolic Disease Cancer

Burosumab (KRN23) is a humanized FGF23-neutralizing antibody. By neutralizing FGF23, Burosumab blocks its inhibitory effect on renal phosphate reabsorption, thereby increasing serum phosphate levels and improving abnormal bone mineralization. Burosumab can be used in the research of diseases such as X-linked hypophosphatemia (XLH) and osteomalacia [1] .
loading...
    loading...
Cat. No.: HY-170952
CAS No.: 3053857-55-6
Research Areas:  

Cancer

LYG-409 is a highly potent, selective, and orally active GSPT1 molecular glue degrader. LYG-409 induces GSPT1 degradation in KG-1 cells with a DC50 of 7.87 nM. LYG-409 binds to Cereblon with an IC50 of 191 nM, promotes the formation of the CRBN-GSPT1 ternary complex, and induces proteasome-dependent degradation of GSPT1. LYG-409 exhibits broad antiproliferative and GSPT1-degrading activities in a variety of hematologic and solid tumor cells. LYG-409 can be used for studies related to GSPT1-targeted protein degradation, acute myeloid leukemia, and prostate cancer [1].
loading...
    loading...
Cat. No.: HY-142656
Target:  

Pim

Research Areas:  

Cancer

PIM-IN-1 is a pan-PIM kinase inhibitor (KG-1, EC50 = 61 nM; pS6, EC50 = 71 nM).
loading...
    loading...
Cat. No.: HY-155529
CAS No.: 1422456-47-0
Target:  

Pim

Research Areas:  

Cancer

FD1024 is PIM inhibitor (IC50s: 1.96, 38.9, 4.17 nM for PIM1, 2, 3). FD1024 can be used for research of acute myeloid leukemia. FD1024 has strong antiproliferative activity against the tested AML cell lines, with 0.16 μM, 0.12 μM, 1.05 μM, 1.39μM for EOL-1, MV-4-11, KG-1, MOLM-16 cells. FD1024 also has antitumor efficacy in mice [1].
loading...
    loading...
Cat. No.: HY-168082
Research Areas:  

Cancer

Dot1L-IN-8 (Compound 15) is a potent Dot1L inhibitor. Dot1L-IN-8 inhibits HL-60, K562, MV4-11, HH, and KG-1 cells vitality with IC50s of 0.45, 1.03, 0.68, 1.66, and 1.12 μM, respectively [1].
loading...
    loading...
Cat. No.: HY-149522
CAS No.: 3034883-70-7
Target:  

Bcl-2 Family Apoptosis

Research Areas:  

Cancer

BCL6-IN-10 (Compound WK499) is a BCL6 inhibitor. BCL6-IN-10 interrupts the binding of BCL6 to SMRT protein. BCL6-IN-10 induces cell apoptosis, cell cycle arrest and DNA damage. BCL6-IN-10 inhibits AML cell proliferation (IC50s: 0.91, 1.63, 1.026, 7.42, 0.87, 0.85μM for OCl-AML3, THP1, MOLM13, HL60, KG1, NB4 cell respectively) [1].
loading...
    loading...
Cat. No.: HY-P84580
Synonyms: ESET; KG1T; KMT1E; KIAA0067; H3-K9-HMTase4; SETDB1

Host:  

Mouse

Application:  

WB, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Monkey

loading...
    loading...
Cat. No.: HY-P84580A
Synonyms: ESET; KG1T; KMT1E; KIAA0067; H3-K9-HMTase4; SETDB1

Host:  

Mouse

Application:  

WB, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Monkey

loading...
    loading...